Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

Target-specific agents used in melanoma are not curative, and chemokines are being implicated in drug-resistance to target-specific agents. Thus, the use of conventional agents in rationale combinations may result in optimization of therapy. Because histone deacetylases participate in tumor developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Laura, Sevko, Alexandra, Cesare, Michelandrea De, Arrighetti, Noemi, Manenti, Giacomo, Ciusani, Emilio, Verderio, Paolo, Ciniselli, Chiara M., Cominetti, Denis, Carenini, Nives, Corna, Elisabetta, Zaffaroni, Nadia, Rodolfo, Monica, Rivoltini, Licia, Umansky, Viktor, Perego, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147342/
https://www.ncbi.nlm.nih.gov/pubmed/24980831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147342/
https://www.ncbi.nlm.nih.gov/pubmed/24980831

Ejemplares similares